TD Asset Management
EUCRU

TD Asset Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

TD Asset Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-43,657
Closed -$436K – 1525
2021
Q4 		$436K Hold
43,657
– – ﹤0.01% 1399
2021
Q3 		$435K Hold
43,657
– – ﹤0.01% 1412
2021
Q2 		$435K Hold
43,657
– – ﹤0.01% 1407
2021
Q1 		$440K Hold
43,657
– – ﹤0.01% 1418
2020
Q4 		$459K Buy
+43,657
New +$443K ﹤0.01% 1345

Other funds holding EUCRU

MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return
SC
Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return